Across TCGA pan-cancer cohorts, LINC02238 RNA is linked to patient survival in 12 of 34 cancer types, making it the most broadly survival-associated LINC02238 data layer.
The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher LINC02238 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC02238 expression acts as an unfavorable survival marker.
UCEC, KIRP, and MESO are the cancer types where LINC02238 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.